| Molecular mechanisms of hepatocellular carcinoma RN Aravalli, CJ Steer, ENK Cressman Hepatology 48 (6), 2047-2063, 2008 | 795 | 2008 |
| Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus RN Aravalli, S Hu, TN Rowen, JM Palmquist, JR Lokensgard The Journal of Immunology 175 (7), 4189-4193, 2005 | 305 | 2005 |
| Cellular and molecular mechanisms of hepatocellular carcinoma: an update RN Aravalli, ENK Cressman, CJ Steer Archives of toxicology 87, 227-247, 2013 | 272 | 2013 |
| Toll-like receptors in defense and damage of the central nervous system RN Aravalli, PK Peterson, JR Lokensgard Journal of neuroimmune pharmacology 2 (4), 297-312, 2007 | 245 | 2007 |
| Shuttle vectors for hyperthermophilic archaea RN Aravalli, RA Garrett Extremophiles 1, 183-192, 1997 | 97 | 1997 |
| General vectors for archaeal hyperthermophiles: strategies based on a mobile intron and a plasmid C Aagaard, I Leviev, RN Aravalli, P Forterre, D Prieur, RA Garrett FEMS microbiology reviews 18 (2-3), 93-104, 1996 | 84 | 1996 |
| Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia RN Aravalli, S Hu, JR Lokensgard Journal of Neuroinflammation 4, 1-7, 2007 | 71 | 2007 |
| Role of innate immunity in the development of hepatocellular carcinoma RN Aravalli World journal of gastroenterology: WJG 19 (43), 7500, 2013 | 67 | 2013 |
| Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-β1 RB Rock, G Gekker, RN Aravalli, S Hu, WS Sheng, PK Peterson Journal of Neuroimmune Pharmacology 3, 143-149, 2008 | 64 | 2008 |
| Growth of Gram-negative bacteria in the presence of organic solvents AN Rajagopal Enzyme and Microbial Technology 19 (8), 606-613, 1996 | 52 | 1996 |
| Differential apoptotic signaling in primary glial cells infected with herpes simplex virus 1 RN Aravalli, S Hu, TN Rowen, G Gekker, JR Lokensgard Journal of neurovirology 12, 501-510, 2006 | 49 | 2006 |
| Inhibition of toll-like receptor signaling in primary murine microglia RN Aravalli, S Hu, JR Lokensgard Journal of neuroimmune pharmacology 3, 5-11, 2008 | 47 | 2008 |
| Archaea and the new age of microorganisms RN Aravalli, Q She, RA Garrett Trends in ecology & evolution 13 (5), 190-194, 1998 | 46 | 1998 |
| Hepatic differentiation of porcine induced pluripotent stem cells in vitro RN Aravalli, ENK Cressman, CJ Steer The Veterinary Journal 194 (3), 369-374, 2012 | 42 | 2012 |
| Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling RN Aravalli, S Hu, JP Woods, JR Lokensgard Journal of neuroinflammation 5, 1-7, 2008 | 41 | 2008 |
| Liver‐targeted gene therapy: Approaches and challenges RN Aravalli, JD Belcher, CJ Steer Liver Transplantation 21 (6), 718-737, 2015 | 37 | 2015 |
| Animal models of cancer in interventional radiology RN Aravalli, J Golzarian, ENK Cressman European radiology 19, 1049-1053, 2009 | 35 | 2009 |
| Immune-mediated therapies for liver cancer RN Aravalli, CJ Steer Genes 8 (2), 76, 2017 | 33 | 2017 |
| Development of microRNA therapeutics for hepatocellular carcinoma RN Aravalli Diagnostics 3 (1), 170-191, 2013 | 33 | 2013 |
| Interspecies organogenesis for human transplantation AT Crane, RN Aravalli, A Asakura, AW Grande, VD Krishna, DF Carlson, ... Cell transplantation 28 (9-10), 1091-1105, 2019 | 29 | 2019 |
